Chapman represented private equity firm ASGARD Partners & Co. and its portfolio company, Angstrom Technology, in connection with the financing of Angstrom's acquisition of two UK-based cleanroom design and production companies, Connect 2 Cleanrooms Limited and Specific Environments Limited. The acquisitions bolster strategic investments in life sciences, cell and gene therapy, biotech, and pharmaceutical end markets. Partner Nick Whitney led the Chapman deal team for both transactions with associate Michael Myones.